泽璟制药股价跌5.1%,格林基金旗下1只基金重仓,持有1.3万股浮亏损失7.49万元

Group 1 - ZaiJing Pharmaceutical experienced a 5.1% decline in stock price, trading at 107.25 CNY per share, with a total market capitalization of 28.39 billion CNY as of October 9 [1] - The company, established on March 18, 2009, specializes in the research, production, and sales of chemical and biological new drugs, with 99.97% of its revenue coming from pharmaceuticals [1] Group 2 - Green Fund has a significant holding in ZaiJing Pharmaceutical, with its Green Xinyue One-Year Holding Mixed A Fund (011775) holding 13,000 shares, representing 1.38% of the fund's net value [2] - The fund has reported a floating loss of approximately 74,900 CNY as of the latest update [2] - The fund manager, Li Huizhong, has a tenure of 11 years and has achieved a best fund return of 70.73% during his management period [2]